Results 101 to 110 of about 1,806 (157)

Pilot Study of Fingolimod Treatment in Neuronal Ceroid Lipofuscinosis Type 1. [PDF]

open access: yesNeurol Genet
Messina M   +11 more
europepmc   +1 more source

Neurodegenerative Diseases in Children: A Comprehensive Review. [PDF]

open access: yesInt J Mol Sci
Ailioaie C   +4 more
europepmc   +1 more source

Neuronal Ceroid Lipofuscinosis-like Disorder in a Dachshund with Sequence Variants in Lysosome-Related Genes. [PDF]

open access: yesGenes (Basel)
Coates JR   +7 more
europepmc   +1 more source

The neuronal ceroid‐lipofuscinoses

Developmental Disabilities Research Reviews, 2013
The neuronal ceroid‐lipofuscinoses (NCL's, Batten disease) represent a group of severe neurodegenerative diseases, which mostly present in childhood. The phenotypes are similar and include visual loss, seizures, loss of motor and cognitive function, and early death.
Dinesh Rakheja
exaly   +3 more sources

Progress in Neuropathology of the Neuronal Ceroid Lipofuscinoses

Molecular Genetics and Metabolism, 1999
Since the last, 6th, International Congress on Neuronal Ceroid-Lipofuscinoses, neuropathological advances in neuronal ceroid lipofuscinoses (NCL) have been made in several areas: (1) In adult NCL (ANCL) lipopigments have now been repeatedly confirmed to contain subunit c of mitochondrial ATP synthase and even sphingolipid activators (saposins).
Alfried Kohlschütter   +2 more
exaly   +3 more sources

Home - About - Disclaimer - Privacy